Relevance and application of sirtuin 3-activated mitophagy in gastric cancer treatment

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Dec 24, 2025; 16(12): 111175
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.111175

Full Size Figure Download Figure

Figure 3 Sirtuin 3 modification deacetylates its substrate in an NAD⁺-dependent manner. His224: Histidine residue.

Citation: Zhao HY, Yu CY, Ye XT, Qian ST, Huang Y, Liu QS. Relevance and application of sirtuin 3-activated mitophagy in gastric cancer treatment. World J Clin Oncol 2025; 16(12): 111175
URL: https://www.wjgnet.com/2218-4333/full/v16/i12/111175.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i12.111175

Zhao HY, Yu CY, Ye XT, Qian ST, Huang Y, Liu QS. Relevance and application of sirtuin 3-activated mitophagy in gastric cancer treatment. World J Clin Oncol 2025; 16(12): 111175 [PMID: 41480168 DOI: 10.5306/wjco.v16.i12.111175]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.